Fernando Junoy appointed Pierre Fabre Laboratories’ International Managing Director

Castres, October 31, 2024 – Pierre Fabre Laboratories announces the appointment of Fernando Junoy as International Managing Director. In this capacity, he reports to Eric Ducournau, Chief Executive Officer, and joins the Executive Committee.

Fernando Junoy’s mission will be to boost the international growth for the company. Pierre Fabre Laboratories generates 70% of its revenue internationally and aims to increase this share to 80% by 2030, while consolidating its profitability and cash flow.

To this end, the international subsidiaries located in Europe, Americas, Asia and Africa, Turkey and the Middle East will be under the responsibility of Fernando Junoy, excluding Spain, Italy, Germany and China. Like France, these historical markets will continue to be managed directly by the Medical Care and Dermo-Cosmetics & Personal Care Business Units (as well as the recently created Medical Care subsidiary in the United States).

Fernando Junoy will prioritize efforts on 5 expansion territories: Mexico, Brazil, Poland, Benelux and the United States (for the dermo-cosmetics business). These territories delivered growth of 17% in 2023 and a combined cumulative turnover of €500 million by 2025. In these territories, he will strive to balance the growth of dermo-cosmetics brands Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer and Darrow, and optimize the potential of new drugs currently being launched in oncology and dermatology.

Born in Spain, Fernando Junoy holds an MBA from ESADE and has 20 years of experience in the field of family health, dermo-cosmetics and medical dermatology, he previously served as Director Europe, Middle East and Africa at Galderma Laboratories. He began his career at Procter & Gamble, then joined the Puig and Johnson & Johnson groups successively.